National Center for Complementary and Integrative Health (NCCIH)

NIH…Turning Discovery Into Health

Follow NCCIH Subscribe to our email update Subscribe to the NCCIH RSS feed Follow NCCIH on FacebookRead our disclaimer about external links Follow NCCIH on TwitterRead our disclaimer about external links

Menu

Public Notification: Infinity Contains Hidden Drug Ingredient

The Food and Drug Administration (FDA) is advising consumers not to purchase or use Infinity, a product promoted and sold for weight loss on various websites, and in some retail stores. http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSa…

 
FDA laboratory analysis confirmed that Infinity contains sibutramine. Sibutramine is a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. These products may also interact, in life-threatening ways, with other medications a consumer may be taking.
 

Read More